Matthew Moll

3.0k total citations
49 papers, 580 citations indexed

About

Matthew Moll is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Matthew Moll has authored 49 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Matthew Moll's work include Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers), Asthma and respiratory diseases (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Matthew Moll is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers), Asthma and respiratory diseases (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Matthew Moll collaborates with scholars based in United States, Canada and United Kingdom. Matthew Moll's co-authors include Christoph Benning, John E. Froehlich, Carl André, Edwin K. Silverman, Michael H. Cho, Brian D. Hobbs, Dandi Qiao, Harrison W. Farber, Auyon Ghosh and Mayank Sardana and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and The Plant Cell.

In The Last Decade

Matthew Moll

45 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Moll United States 13 193 181 129 99 84 49 580
Alessandro Venosa United States 18 299 1.5× 446 2.5× 134 1.0× 113 1.1× 30 0.4× 39 946
Shiro YAMADA Japan 12 182 0.9× 51 0.3× 83 0.6× 67 0.7× 16 0.2× 46 489
Diane L. Kachel United States 13 151 0.8× 180 1.0× 21 0.2× 54 0.5× 34 0.4× 20 536
Guicheng Wu China 11 193 1.0× 28 0.2× 43 0.3× 61 0.6× 18 0.2× 39 516
John Sherwin United States 13 170 0.9× 35 0.2× 45 0.3× 47 0.5× 47 0.6× 24 529
Khalid Hassan Pakistan 11 290 1.5× 69 0.4× 26 0.2× 249 2.5× 16 0.2× 43 820
Elizabeth Joseloff United States 14 294 1.5× 689 3.8× 36 0.3× 93 0.9× 9 0.1× 21 1.0k
Ali Amini Harandi Iran 11 72 0.4× 52 0.3× 120 0.9× 17 0.2× 35 0.4× 19 403
Yu Zhu China 15 282 1.5× 39 0.2× 25 0.2× 139 1.4× 12 0.1× 65 783
Paola Tomei Italy 9 120 0.6× 32 0.2× 54 0.4× 23 0.2× 15 0.2× 20 364

Countries citing papers authored by Matthew Moll

Since Specialization
Citations

This map shows the geographic impact of Matthew Moll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Moll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Moll more than expected).

Fields of papers citing papers by Matthew Moll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Moll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Moll. The network helps show where Matthew Moll may publish in the future.

Co-authorship network of co-authors of Matthew Moll

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Moll. A scholar is included among the top collaborators of Matthew Moll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Moll. Matthew Moll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moll, Matthew, et al.. (2025). Assessing Inflammatory Protein Biomarkers in COPD Subjects With and Without Alpha-1 Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3191–A3191.
2.
Ziyatdinov, Andrey, Brian D. Hobbs, Matthew Moll, et al.. (2025). Identifying chronic obstructive pulmonary disease subtypes using multi-trait genetics. EBioMedicine. 113. 105609–105609. 1 indexed citations
3.
Moll, Matthew, Brian D. Hobbs, Katherine Pratte, et al.. (2025). Assessing inflammatory protein biomarkers in COPD subjects with and without alpha-1 antitrypsin deficiency. Respiratory Research. 26(1). 247–247. 2 indexed citations
4.
Zhang, Jingzhou, Matthew Moll, Brian D. Hobbs, et al.. (2024). Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 210(7). 890–899. 5 indexed citations
5.
Rose, Jonathan A., Ann-Marcia C. Tukpah, Claire C. Cutting, et al.. (2024). Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene. American Journal of Respiratory and Critical Care Medicine. 210(12). 1453–1460. 3 indexed citations
6.
Gregory, Andrew, Zhonghui Xu, Sharon M. Lutz, et al.. (2023). Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema. American Journal of Respiratory and Critical Care Medicine. 209(3). 273–287. 6 indexed citations
7.
Tukpah, Ann-Marcia C., Julie Sullivan, Gerald L. Weinhouse, et al.. (2023). Cluster analysis of COVID-19 recovery center patients at a clinic in Boston, MA 2021–2022: impact on strategies for access and personalized care. Archives of Public Health. 81(1). 39–39.
8.
McDermott, Gregory C, Keigo Hayashi, Kazuki Yoshida, et al.. (2023). Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers. Lara D. Veeken. 64(1). 133–142. 4 indexed citations
9.
10.
Hecker, Julian, Dmitry Prokopenko, Matthew Moll, et al.. (2022). A robust and adaptive framework for interaction testing in quantitative traits between multiple genetic loci and exposure variables. PLoS Genetics. 18(11). e1010464–e1010464. 3 indexed citations
11.
Moll, Matthew, Adel Boueiz, Auyon Ghosh, et al.. (2021). Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 205(2). 161–170. 18 indexed citations
12.
Moll, Matthew, Sharon M. Lutz, Auyon Ghosh, et al.. (2020). Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies. BMJ Open Respiratory Research. 7(1). e000755–e000755. 10 indexed citations
13.
Moll, Matthew, et al.. (2020). Introduction of an academic medical center’s point-of-care ultrasound curriculum to internal medicine residents at a community-based teaching hospital. Journal of Community Hospital Internal Medicine Perspectives. 10(2). 93–98. 1 indexed citations
14.
McElvaney, Oliver J., Brian D. Hobbs, Dandi Qiao, et al.. (2020). A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine. 61. 103026–103026. 62 indexed citations
15.
Moll, Matthew, Elizabeth A. Regan, John E. Hokanson, et al.. (2020). The Association of Multiparity with Lung Function and Chronic Obstructive Pulmonary Disease-Related Phenotypes. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 7(2). 86–98. 7 indexed citations
16.
17.
Moll, Matthew, Romy Christmann, Yuqing Zhang, et al.. (2018). Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung disease. Journal of Scleroderma and Related Disorders. 3(3). 242–248. 11 indexed citations
18.
Moll, Matthew, et al.. (2015). Creation and Evaluation of a Novel Point-of-Care Ultrasound Program for Internal Medicine Residents. CHEST Journal. 148(4). 464A–464A. 1 indexed citations
19.
Moll, Matthew, et al.. (2015). Gestational Pulmonary Arterial Hypertension. Pulmonary Circulation. 5(4). 730–733. 5 indexed citations
20.
Sardana, Mayank, Matthew Moll, & Harrison W. Farber. (2015). Novel investigational therapies for treating pulmonary arterial hypertension. Expert Opinion on Investigational Drugs. 24(12). 1571–1596. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Venosa Breakdown of academic impact, for papers by Shiro YAMADA Breakdown of academic impact, for papers by Diane L. Kachel Breakdown of academic impact, for papers by Guicheng Wu Breakdown of academic impact, for papers by John Sherwin Breakdown of academic impact, for papers by Khalid Hassan Breakdown of academic impact, for papers by Elizabeth Joseloff Breakdown of academic impact, for papers by Ali Amini Harandi Breakdown of academic impact, for papers by Yu Zhu Breakdown of academic impact, for papers by Paola Tomei
Rankless by CCL
2026